Literature DB >> 22006773

Joseph-Claude-Anthelme Récamier (1774-1852): forerunner in surgical oncology.

G Androutsos1, M Karamanou, E Stamboulis, G Tsoucalas, A A Kousoulis, D Mandelenaki.   

Abstract

Professor J.C.A. Récamier (1774-1852), the undisputed founder of modern gynecologic surgery, had also excelled in the field of oncology. In particular, he performed the first successful vaginal hysterectomy for cancer; he conducted extensive research on cancer metastatic process and he was the proponent of a cancer treatment method by compression.

Entities:  

Mesh:

Year:  2011        PMID: 22006773

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  4 in total

Review 1.  Evolution of Medical Approaches and Prominent Therapies in Breast Cancer.

Authors:  Suzann Duan; Iain L O Buxton
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

Review 2.  The cancer diaspora: Metastasis beyond the seed and soil hypothesis.

Authors:  Kenneth J Pienta; Bruce A Robertson; Donald S Coffey; Russell S Taichman
Journal:  Clin Cancer Res       Date:  2013-10-07       Impact factor: 12.531

3.  Novel evidence that pituitary sex hormones regulate migration, adhesion, and proliferation of embryonic stem cells and teratocarcinoma cells.

Authors:  Zachariah Payne Sellers; Kamila Bujko; Gabriela Schneider; Magdalena Kucia; Mariusz Z Ratajczak
Journal:  Oncol Rep       Date:  2017-11-24       Impact factor: 3.906

4.  Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062).

Authors:  Krishnansu S Tewari; Michael W Sill; Bradley J Monk; Richard T Penson; David H Moore; Heather A Lankes; Lois M Ramondetta; Lisa M Landrum; Leslie M Randall; Ana Oaknin; Mario M Leitao; Eric L Eisenhauer; Paul DiSilvestro; Linda Van Le; Michael L Pearl; James J Burke; Ritu Salani; Debra L Richardson; Helen E Michael; David W Kindelberger; Michael J Birrer
Journal:  Mol Cancer Ther       Date:  2020-08-26       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.